iSpecimen

iSpecimen

Biotechnology Research

Lexington, MA 2,583 followers

NASDAQ: ISPC

About us

iSpecimen was founded to address a critical challenge: how to efficiently connect life science researchers who need human biospecimens with the billions of specimens available in healthcare organizations worldwide. Our ground-breaking iSpecimen Marketplace® aids in solving this problem, reinventing the biospecimen procurement process to help accelerate medical discovery. We have worked tirelessly to build our provider network and marketplace platform, expanding streamlined access to high-quality specimens to efficiently meet the growing demand for human biospecimens. Through our innovative iSpecimen Marketplace, we simplify the interaction between researchers and biospecimen providers. For researchers, our platform offers a single, easy-to-use interface and standardized process for accessing a global network of providers to biospecimen requests. For specimen providers, we offer an array of connections to pre-qualified research customers worldwide. Through our network, providers are able to share specimens with researchers for the benefit of science while also generating a steady stream of sustainable revenue. With iSpecimen, the world is your biobank. This approach has been such a success that we recently took the company public to further accelerate the development of the iSpecimen Marketplace Platform. Moving forward, we plan to expand our global sample provider network and continue to meet the ever-growing researcher need for fresh, highly-specific human biospecimens and data from large and diverse patient pools. Our mission is to accelerate biomedical advances by making it easy for researchers to unlock the large volume of human biospecimens hidden in healthcare organizations.

Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
Lexington, MA
Type
Public Company
Founded
2009
Specialties
Annotated Human Biospecimens, Biofluids, Solid Tissue, and Cells with Associated De-Identified Data, Soon-to-be-Discarded, Banked, or Collected for Research, and Disease-state and Normal Samples

Locations

Employees at iSpecimen

Updates

Similar pages

Browse jobs

Funding

iSpecimen 3 total rounds

Last Round

Post IPO equity

US$ 21.0M

See more info on crunchbase